TGTX Competitors & Alternatives
Compare TG Therapeutics Inc with similar stocks in the same industry
Biotechnology
TGTX
Main Stock$40.79
Tradestie Score
61
Market Cap
$5.80B
P/E Ratio
14.9
Revenue Growth
0.7%
Analyst Upside
+18.0%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$78.64
|
$6.68B | - | 60 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$93.63
|
$6.64B | - | 60 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$121.00
|
$6.38B | - | 54 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$28.60
|
$6.03B | - | 62 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$50.45
|
$6.02B | - | 58 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$104.41
|
$5.95B | - | 60 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$232.27
|
$5.92B | - | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$316.30
|
$5.20B | 42.0 | 58 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$53.53
|
$4.94B | - | 54 | Compare |
More TGTX Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry